Indirect airway challenges

European Respiratory Journal - Tập 21 Số 6 - Trang 1050-1068 - 2003
G.F. Joos1, B J O'Connor1
1Dept Respiratory Diseases Ghent University Hospital De Pintelaan 185 B-9000 Ghent Belgium

Tóm tắt

Indirect challenges act by causing the release of endogenous mediators that cause the airway smooth muscle to contract. This is in contrast to the direct challenges where agonists such as methacholine or histamine cause airflow limitation predominantlyviaa direct effect on airway smooth muscle.Direct airway challenges have been used widely and are well standardised. They are highly sensitive, but not specific to asthma and can be used to exclude current asthma in a clinic population. Indirect bronchial stimuli, in particular exercise, hyperventilation, hypertonic aerosols, as well as adenosine, may reflect more directly the ongoing airway inflammation and are therefore more specific to identify active asthma. They are increasingly used to evaluate the prevalence of bronchial hyperresponsiveness and to assess specific problems in patients with known asthma,e.g.exercise-induced bronchoconstriction, evaluation before scuba diving.Direct bronchial responsiveness is only slowly and to a modest extent, influenced by repeated administration of inhaled steroids. Indirect challenges may reflect more closely acute changes in airway inflammation and a change in responsiveness to an indirect stimulus may be a clinically relevant marker to assess the clinical course of asthma. Moreover, some of the indirect challenges,e.g.hypertonic saline and mannitol, can be combined with the assessment of inflammatory cells by induction of sputum.

Từ khóa


Tài liệu tham khảo

10.1183/09041950.053s1693

2000, Thorax, 53, 419

1992, Am Rev Respir Dis, 145, 301, 10.1164/ajrccm/145.2_Pt_1.301

10.1136/thx.36.8.575

1996, Am J Respir Crit Care Med, 153, 1802, 10.1164/ajrccm.153.6.8665038

10.1111/j.1365-2222.1988.tb02878.x

10.1034/j.1399-3003.2000.016003514.x

1993, Am Rev Respir Dis, 148, 950, 10.1164/ajrccm/148.4_Pt_1.950

1996, Respiration, 63, 304, 10.1159/000196565

10.1378/chest.105.5.1434

2001, Am J Respir Crit Care Med, 163, 1546, 10.1164/ajrccm.163.7.2010145

10.1136/thx.51.6.582

10.1002/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7

1999, Am J Respir Crit Care Med, 160, 237, 10.1164/ajrccm.160.1.9809046

10.1056/NEJM199405123301907

10.1067/mai.2000.109822

1987, Am Rev Respir Dis, 135, 1043

1984, Br Med J (Clin Res Ed ), 288, 1496, 10.1136/bmj.288.6429.1496

1990, Eur Respir J, 3, 540, 10.1183/09031936.93.03050540

10.1378/chest.93.5.937

10.1183/09031936.98.12020345

1998, Clin Exp Allergy, 28, 181

10.1016/0091-6749(92)90294-C

1997, Thorax, 52, 1030, 10.1136/thx.52.12.1030

1990, Am Rev Respir Dis, 142, 73, 10.1164/ajrccm/142.1.73

10.1056/NEJM199012203232505

10.1164/ajrccm.155.3.9117020

1998, Eur Respir J, 11, 617, 10.1183/09031936.98.11030617

10.1056/NEJM199807163390302

10.1016/0090-6980(90)90028-T

2000, Am J Respir Crit Care Med, 159, 634

10.1016/0091-6749(84)90296-3

1984, N Engl J Med, 311, 883, 10.1056/NEJM198410043111404

10.1164/ajrccm.153.3.8630576

10.1016/S0091-6749(87)80018-0

1988, Lancet, 2, 252

1993, Eur Respir J, 6, 652, 10.1183/09031936.93.06050652

10.1164/ajrccm/141.1.9

10.1016/0091-6749(91)90415-K

10.1164/ajrccm/136.2.369

10.1016/0091-6749(89)90106-1

10.1164/ajrccm/139.2.463

10.1016/0006-2952(84)90050-9

1995, Am J Respir Crit Care Med, 151, 624

10.1136/thx.42.12.939

1995, Eur Respir J, 8, 905, 10.1183/09031936.95.08060905

10.1136/thx.51.8.799

1992, Eur Respir J, 5, 560, 10.1183/09031936.93.05050560

10.1183/09031936.97.10112460

1996, Am J Physiol, 271, L763, 10.1152/ajpcell.1996.271.3.C763

10.1016/0140-6736(92)92948-F

1996, Am J Respir Crit Care Med, 153, 1781, 10.1164/ajrccm.153.6.8665034

10.1111/j.1365-2222.1995.tb01024.x

2001, Am J Respir Crit Care Med, 163, A418

10.1016/0952-0600(88)90009-9

1990, Ann Allergy, 65, 115

10.1164/ajrccm.149.1.7509245

10.1164/ajrccm.150.4.7921430

1990, Allergy, 45, 174, 10.1111/j.1398-9995.1990.tb00480.x

1987, Am Rev Respir Dis, 135, 176

10.1007/s002280050106

1997, Eur Respir J, 10, 866, 10.1183/09031936.97.10040866

1989, Respiration, 55, 181, 10.1159/000195730

Ind PW, Barnes PJ, Durham SR, Kay AB. Propranolol-induced bronchoconstriction in asthma: beta-receptor blockade and mediator release. Am Rev Respir Dis 1984;129:Suppl. A10.

1991, Curr Ther Res, 49, 507

10.1164/ajrccm/139.6.1390

10.1016/0091-6749(87)90034-0

10.1007/BF00542137

10.1183/09031936.94.07010050

10.1136/thx.51.2.159

1997, Am J Respir Crit Care Med, 156, 1725, 10.1164/ajrccm.156.6.9608006

1965, J Appl Physiol, 20, 164, 10.1152/jappl.1965.20.1.164

1980, Am Rev Respir Dis, 122, 873

1992, Br J Clin Pharmacol, 34, 71, 10.1111/j.1365-2125.1992.tb04110.x

1994, Am J Respir Crit Care Med, 150, 853, 10.1164/ajrccm.150.3.8087360

10.1016/0091-6749(89)90101-2

10.1067/mai.2000.108914

1997, Am J Respir Crit Care Med, 155, 170, 10.1164/ajrccm.155.1.9001307

1992, Am Rev Respir Dis, 145, 746, 10.1164/ajrccm/145.4_Pt_1.746

1992, Am Rev Respir Dis, 145, 1285, 10.1164/ajrccm/145.6.1285

10.1111/j.1365-2222.1982.tb02539.x

10.1136/thx.37.10.737

1991, Br J Pharmacol, 102, 931, 10.1111/j.1476-5381.1991.tb12279.x

10.1164/ajrccm/137.3.641

1989, Am Rev Respir Dis, 140, 593, 10.1164/ajrccm/140.3.593

2001, Am J Respir Crit Care Med, 163, 1420, 10.1164/ajrccm.163.6.2006019

10.1016/0091-6749(93)90041-D

Altounyan REC, Lee TB, Rocchiccioli MS, Shaw CL. A comparison of the inhibitory effects of nedocromil sodium and sodium cromoglycate on adenosine monophosphate-induced bronchoconstriction in atopic subjects. Eur J Respir Dis 1986;69:Suppl. 277–279.

10.1016/0091-6749(88)90913-X

1992, Eur Respir J, 5, 323, 10.1183/09031936.93.05030323

1995, Am J Respir Crit Care Med, 152, 1203, 10.1164/ajrccm.152.4.7551371

1982, J Appl Physiol, 53, 169, 10.1152/jappl.1982.53.1.169

10.1136/thx.39.8.588

1986, Am Rev Respir Dis, 133, 1154

1987, Am Rev Respir Dis, 136, S28, 10.1164/ajrccm/136.4_Pt_2.S28

1993, Eur Respir J, 6, 1018, 10.1183/09031936.93.06071018

1993, Eur Respir J, 6, 1138

10.1016/0091-6749(93)90320-F

1991, Adv Prostaglandin Thromboxane Leukot Res, 21A, 433

2000, Am J Respir Crit Care Med, 161, 1553, 10.1164/ajrccm.161.5.9906068

1993, Am Rev Respir Dis, 147, 839, 10.1164/ajrccm/147.4.839

10.1111/j.1365-2222.1996.tb00572.x

1997, Am J Respir Crit Care Med, 155, 1856, 10.1164/ajrccm.155.6.9196086

10.1002/(SICI)1098-2299(199611/12)39:3/4<262::AID-DDR5>3.0.CO;2-P

10.1016/S0165-6147(98)01179-1

10.1002/(SICI)1098-2299(199611/12)39:3/4<330::AID-DDR13>3.0.CO;2-5

1993, Eur Respir J, 6, 735, 10.1183/09031936.93.06050735

1989, Am Rev Respir Dis, 140, 679, 10.1164/ajrccm/140.3.679

1992, Am Rev Respir Dis, 146, 1177, 10.1164/ajrccm/146.5_Pt_1.1177

1993, J Pharmacol Exp Ther, 267, 95

10.1164/ajrccm.163.5.2002079

10.1016/0091-6749(89)90080-8

10.1016/S0165-6147(00)01458-9

10.1183/09031936.98.12010017

10.1183/09031936.98.12061454

1993, Am Rev Respir Dis, 148, 1467, 10.1164/ajrccm/148.6_Pt_1.1467

Nadel JA.. Peptidase modulation of neurogenic inflammation In: Geppetti P, Holzer P, ed. Neurogenic inflammationBoca Raton, CRC Press, 1996; 115–127.

10.1164/ajrccm/142.6_Pt_1.1367

Proud D.. Kinins as mediators of lung disease In: Crystal RG, West JB, Barnes PJ, Weibel ER, editors. The LungPhiladelphia, Lippincott Raven, 1997; 89–101.

10.1016/S0140-6736(96)04450-9

10.1016/0167-0115(93)90268-D

1990, J Pharmacol Exp Ther, 253, 594

10.1164/ajrccm/137.6.1330

1986, Am Rev Respir Dis, 134, 704

10.1164/ajrccm/143.6.1438

10.1111/j.1365-2222.1977.tb01448.x

Juniper EF, Cockcroft DW, Hargreave FE.. Histamine and methacholine inhalatation tests: tidal breathing method - laboratory procedure and standardisationLund, Sweden, AB Draco, 1994.

10.1016/0091-6749(75)90107-4

10.1016/0091-6749(81)90012-9

10.1136/thx.38.10.760

10.1136/thx.33.6.705

Woolcock AJ.. Expression of results of airway hyperresponsiveness In: Hargreave FE, Woolcock AJ, editors. Airway Hyperresponsiveness Measurement and InterpretationCanada, Astra Pharmaceuticals Canada Ltd, 1985; pp. 80–90.

10.1136/thx.38.7.516

10.1016/0091-6749(79)90014-9

10.1016/0091-6749(84)90279-3

1991, Eur Respir J, 4, 1093, 10.1183/09031936.93.04091093

10.1016/S0091-6749(05)80037-5

1982, Am Rev Respir Dis, 126, 829

10.1136/thx.39.12.912

10.1136/thx.40.6.422

10.1378/chest.94.3.457

10.1016/0091-6749(79)90125-8

10.1016/0091-6749(79)90199-4

10.1016/0091-6749(84)90303-8

1988, Pediatr Pulmonol, 4, 2, 10.1002/ppul.1950040103

1991, J Asthma, 28, 31, 10.3109/02770909109073368

10.1378/chest.102.2.347

1996, Pediatr Allergy Immunol, 7, 141, 10.1111/j.1399-3038.1996.tb00121.x

10.1034/j.1399-3003.1999.14c28.x

10.1067/mai.2002.127784

10.1136/thx.46.7.488

10.1136/thx.50.5.511

10.1002/(SICI)1099-0496(199609)22:3<147::AID-PPUL2>3.0.CO;2-M

10.1183/09031936.98.12040879

10.1164/ajrccm.161.1.ats11-99

10.1136/bjsm.35.5.344

10.1378/chest.108.3.741

2000, Am J Respir Crit Care Med, 161, 1805, 10.1164/ajrccm.161.6.9905098

10.1111/j.1365-2222.1993.tb01794.x

Anderson SD, Gibson P.. The use of aerosols of hypertonic saline and distilled water (fog) for the patient with asthma In: Barnes PJ, Grunstein MM, Leff A, Woolcock AJ, ed. AsthmaNew York, Raven Press, 1997; pp. 1135–1150.

1997, Am J Respir Crit Care Med, 156, 758, 10.1164/ajrccm.156.3.9701113

1998, Am J Respir Crit Care Med, 158, 1120, 10.1164/ajrccm.158.4.9802087

1994, Am J Respir Crit Care Med, 150, 1632, 10.1164/ajrccm.150.6.7952626

1996, Occup Med (Lond), 46, 177, 10.1093/occmed/46.3.177

1990, Eur Respir J, 3, 144, 10.1183/09031936.93.03020144

1989, Eur Respir J, 2, 44, 10.1183/09031936.93.02010044

1995, SPUMS Journal, 25, 233

1990, Eur Respir J, 3, 1114, 10.1183/09031936.93.03101114

10.1183/09031936.96.09040725

1999, Am J Respir Crit Care Med, 159, 1843, 10.1164/ajrccm.159.6.9809074

10.1034/j.1399-3003.1999.14c30.x

10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M

10.1002/(SICI)1099-0496(199605)21:5<282::AID-PPUL3>3.0.CO;2-P

1984, Am Rev Respir Dis, 129, 211

1983, Am Rev Respir Dis, 127, 691

10.1136/thx.47.1.25

1995, Am J Respir Crit Care Med, 152, 53, 10.1164/ajrccm.152.1.7599862

10.1067/mai.2000.105319

1999, Am J Respir Crit Care Med, 160, 93, 10.1164/ajrccm.160.1.9809104

10.1111/j.1365-2222.1994.tb02725.x

1980, Eur J Respir Dis., 61, 41

1981, Br Med J, 283, 1285, 10.1136/bmj.283.6302.1285

1983, Am Rev Respir Dis, 127, 691

1984, Am Rev Respir Dis, 129, 211

1985, Clin Rev Allergy, 3, 427

10.2500/108854191778879430

10.1378/chest.90.6.822

1987, Ann Allergy, 58, 134

10.1063/1.349682

1989, Ann Allergy, 62, 180

10.1111/j.1365-2125.1983.tb01481.x

1999, Thorax, 54, 230, 10.1136/thx.54.3.230

10.1164/ajrccm/147.3.553

1988, Respiration, 54, 84, 10.1159/000195482

1986, AmJ Respir Crit Care Med, 133, A177

1997, Am J Respir Crit Care Med, 156, 1151, 10.1164/ajrccm.156.4.9607025

10.1016/S0091-6749(99)70106-5

1997, IRCS J Med Sci, 5, 129

10.1016/0091-6749(89)90330-8

1990, Eur Respir J, 3, 527, 10.1183/09031936.93.03050527

1993, Ann Allergy, 71, 61

1982, J Allergy Clin Immunol, 69, 11

1989, Ann Allergy, 63, 159

1998, Am J Respir Crit Care Med, 158, 1168, 10.1164/ajrccm.158.4.9710043

10.1067/mai.2000.108307

1990, Am Rev Respir Dis, 142, 832, 10.1164/ajrccm/142.4.832

1987, J Allergy Clin Immunol, 79, 653, 10.1016/S0091-6749(87)80163-X

1999, Am J Respir Crit Care Med, 159, 1043, 10.1164/ajrccm.159.4.9806052

10.1183/09031936.00.15103000

1992, Am Rev Respir Dis, 146, 560, 10.1164/ajrccm/146.3.560

10.1002/(SICI)1099-0496(199706)23:6<404::AID-PPUL2>3.0.CO;2-I

1994, Am J Respir Crit Care Med, 150, 381, 10.1164/ajrccm.150.2.8049819

10.1056/NEJM199210223271704

2001, Am J Respir Crit Care Med, 163, 406, 10.1164/ajrccm.163.2.9912091

1992, Eur Respir J, 5, 953, 10.1183/09031936.93.05080953

2000, Am J Respir Crit Care Med, 161, 2096, 10.1164/ajrccm.161.6.9908096

1994, Chest, 105, 673, 10.1378/chest.105.3.673

10.1046/j.1440-1843.2002.00357.x

1968, Les Bronches, 18, 439

10.1034/j.1399-3003.2000.16a27.x

10.1016/S0091-6749(95)70149-4

10.1016/S0091-6749(05)80155-1

10.1136/thx.46.11.811

10.1378/chest.100.3.670

1992, Eur Respir J, 5, 1075, 10.1183/09031936.93.05091075

10.1136/thx.50.10.1044

1997, Am J Respir Crit Care Med, 155, 1241, 10.1164/ajrccm.155.4.9105061

10.1164/ajrccm.164.7.2102135

1995, Eur Respir J, 8, 729, 10.1183/09031936.95.08050729

10.1111/j.1365-2222.1987.tb02015.x

10.1016/S0091-6749(95)70088-9

1997, Am J Respir Crit Care Med, 156, 299, 10.1164/ajrccm.156.1.9610114

2001, Am J Respir Crit Care Med, 164, 1146, 10.1164/ajrccm.164.7.2103015

10.1111/j.1365-2125.1985.tb02696.x

10.1111/j.1365-2222.1988.tb02884.x

1996, Am J Respir Crit Care Med, 153, 931, 10.1164/ajrccm.153.3.8630575

Dahlen B.. Leukotrienes as mediators of asthma induced by aspirin and allergenKarolinska Instituet, Stockholm, Sweden (PhD). 1993.

Thông tin
Thông tin xuất bản

European Respiratory Journal

Tập 21 Số 6

1050-1068

Thông tin tác giả